Singapore markets closed

Korro Bio, Inc. (KRRO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
37.46-0.86 (-2.25%)
As of 12:45PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
Total revenue
0
0
0
0
Operating expenses
Research development
56,128
57,250
42,201
23,805
Selling general and administrative
29,773
27,284
16,797
11,689
Total operating expenses
85,901
84,534
58,998
35,494
Operating income or loss
-85,901
-84,534
-58,998
-35,494
Interest expense
-
-
118
-
Total other income/expenses net
4,821
3,389
976
13,537
Income before tax
-81,080
-81,145
-58,022
-21,957
Income tax expense
44
27
10
2
Income from continuing operations
-81,124
-81,172
-58,032
-21,959
Net income
-81,124
-81,172
-58,032
-21,959
Net income available to common shareholders
-81,124
-81,172
-58,032
-21,959
Basic EPS
-8.58
-53.08
-7.25
-2.74
Diluted EPS
-8.58
-53.08
-7.25
-2.74
Basic average shares
8,001
1,529
8,001
8,001
Diluted average shares
8,001
1,529
8,001
8,001